Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1Cohance Lifesciences
02 1ANI Pharmaceuticals Inc
03 2Actavis Inc
04 3Avet Pharmaceuticals
05 2Dastech International Inc
06 2Merck & Co
07 2PUREPAC PHARM
08 2Teva Pharmaceutical Industries
09 1Zydus Pharmaceuticals
01 15TABLET;ORAL
02 1Tablet
01 10DISCN
02 5RX
03 1Blank
01 13DIFLUNISAL
02 2DOLOBID
03 1Blank
01 1India
02 15USA
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DIFLUNISAL
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 1997-07-17
Application Number : 74400
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DIFLUNISAL
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 1997-07-17
Application Number : 74400
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DIFLUNISAL
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 1996-06-10
Application Number : 74604
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DIFLUNISAL
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2012-03-08
Application Number : 202845
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DIFLUNISAL
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2024-08-16
Application Number : 202845
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DIFLUNISAL
Dosage Form : TABLET;ORAL
Dosage Strength : 375MG
Packaging :
Approval Date : 2024-08-16
Application Number : 202845
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DIFLUNISAL
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 1992-11-27
Application Number : 73562
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DIFLUNISAL
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 1992-11-27
Application Number : 73563
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOLOBID
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-04-19
Application Number : 18445
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOLOBID
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-04-19
Application Number : 18445
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DIFLUNISAL
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 1996-05-07
Application Number : 74285
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DIFLUNISAL
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 1996-05-07
Application Number : 74285
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DIFLUNISAL
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 1992-07-31
Application Number : 73673
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DIFLUNISAL
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 1992-07-31
Application Number : 73679
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DIFLUNISAL
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2017-06-16
Application Number : 203547
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?